Screening Protocol for Adults With ADHD

ADHD Clinical Trial

Official title:

A Screening Protocol for Adults With Attention Deficit Hyperactivity Disorder

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00592254
• Other study ID #: 2002-P-001856
• Status: Active, not recruiting
• Start date: December 2002
• Est. completion date: December 2023

Study information

• Verified date: January 2022
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential adult subjects for appropriate ADHD clinical research studies

Description:

To address the needs of the large number of adults who contact the Adult ADHD Program at Massachusetts General Hospital annually, we have sought approval for several research studies aimed at evaluating critical components of the needs of this population. Potential participants for those studies present with a widely varied set of complaints not always discernable in a telephone screening interview. This state of affairs often makes it difficult to ask subjects to sign a specific protocol's consent form without obtaining additional clinical information. Because of this, we have potential subjects consent to undergo an in-depth clinical assessment that will allow them to be screened by a clinician for eligibility to a diverse clinical research program available to them.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 3000
• Est. completion date: December 2023
• Est. primary completion date: December 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

1. Males and females ages 18-55

2. Subjects must have a DSM-IV or DSM-V diagnosis of ADHD, as determined by a clinical evaluation based on DSM-IV or DSM-V criteria

Exclusion Criteria:

1. History of head trauma with loss of consciousness, organic brain disorders, seizures, or neurosurgical intervention.

2. Any significant medical condition, in the judgment of the investigator

3. Mental retardation

4. Pregnancy of lactation

5. Subjects with a known recent history (within the past 6 months) of illicit drug or alcohol dependence

6. Sensory difficulties such as deafness or blindness

Related Conditions & MeSH terms

• ADHD

Locations

Country	Name	City	State
United States	Massachusetts General Hospital	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Screening Protocol	This study is a prescreening for possible entry into other studies	Sreening

External Links

•   Related Info